However, the expression levels of cancer stemness markers (EpCAM, Nanog and ALDH1A1) were much suppressed in MDA-MB-231 mammospheres (Day 14) in response to Oligo-Fucoidan or the combined treatment than olaparib alone (Fig. 3C). This evidence concerns the gene EPCAM and cancer.